Advertisement
Australia markets closed
  • ALL ORDS

    7,935.70
    -99.20 (-1.23%)
     
  • AUD/USD

    0.6654
    +0.0002 (+0.03%)
     
  • ASX 200

    7,665.60
    -101.10 (-1.30%)
     
  • OIL

    80.56
    +0.73 (+0.91%)
     
  • GOLD

    2,350.90
    -5.60 (-0.24%)
     
  • Bitcoin AUD

    101,933.82
    -126.94 (-0.12%)
     
  • CMC Crypto 200

    1,456.87
    -27.83 (-1.87%)
     

Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference

Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc.

PRINCETON, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.

ADVERTISEMENT

CONTACT:

Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809

Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications

dmoore@amicusrx.com
(609) 662-5079

FOLD–G